- Home
- BLFS vs BCX Comparison
BLFS vs BCX Comparison
Compare BLFS & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLFS | BCX |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.5M | 949.9M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLFS | BCX |
|---|---|---|
| Price | $21.91 | $12.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 326.0K | 165.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.99% |
| EPS Growth | ★ 77.27 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $96,214,000.00 | N/A |
| Revenue This Year | $19.73 | N/A |
| Revenue Next Year | $17.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $17.86 | $9.12 |
| 52 Week High | $29.57 | $13.86 |
Technical Indicators
Market Signals| Indicator | BLFS | BCX |
|---|---|---|
| Relative Strength Index (RSI) | 56.20 | 50.06 |
| Support Level | $21.35 | $11.91 |
| Resistance Level | $26.14 | $12.54 |
| Average True Range (ATR) | 1.03 | 0.19 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 68.35 | 48.44 |
Price Performance
Historical ComparisonAbout BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About BCX BlackRock Resources of Beneficial Interest
BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies, or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.